Search Results

Concomitant nodal involvement by Langerhans Cell Histiocytosis and Hodgkin Lymphoma

• Authors : Geurten, Claire; THIRY, Albert; Jamblin, Paul

Subjects: Langerhans cell histiocytosis; Hodgkin lymphoma; Pediatricinternational

Record details

Increasing incidence of non-Hodgkin lymphoma in England, 1985–2019

• Authors : M Bawa; Y Salari; E Taylor-Gallardo

Subjects: non-Hodgkin lymphoma; Epidemiology; Incidence

Record details

Study of the efficacy of novel bispecific antibodies targeting immune checkpoints in a 3D model of B non-Hodgkin lymphoma.

• Authors : Gower, N.; Gava, F.; Rimailho, L. ...

Subjects: Immunotherapy; Indolent non‐Hodgkin lymphoma; Risk ModelsLugano; Switzerland

• Source: International Conference on Malignant Lymphoma ; https://inserm.hal.science/inserm-04830782 ; International Conference on Malignant

Record details

Data Requirements for Development of Prediction Models For survival Among Hodgkin Lymphoma Patients: How Many Patients are Needed?

• Authors : Jørgensen, Rasmus Rask Kragh; Jakobsen, Lasse Hjort; El-Galaly, Tarec Christoffer

• Source: Jørgensen , R R K , Jakobsen , L H , El-Galaly , T C & Simonsen , M R 2024 , ' Data Requirements for Development of Prediction Models For survival Among Hodgkin

Record details

1483 Activity of IDP-023 allogeneic g-NK cells without antibody targeting in first-in-human phase 1/2 study in patients with advanced multiple myeloma or non-hodgkin lymphoma

• Authors : Patel, Krina; Gandhi, Mitul; Sankar, Neil

• Source: Late-Breaking Abstracts ; page A1713-A1713

Record details

1195 Multi-modal spatial analysis of classic Hodgkin lymphoma microenvironments utilizing multiplex immunofluorescence and virtual staining

• Authors : Levin, Matt; Alexanian, Serge; Kallen, Michael

• Source: Regular and Young Investigator Award Abstracts ; page A1332-A1332

Record details

1083 Preclinical characterization of IPH6501: a novel IL2v-armed tetraspecific NK cell engager targeting CD20 in relapsed or refractory B cell non-Hodgkin lymphoma subtypes and post-CAR-T therapy

• Authors : Carrette, Florent; Demaria, Olivier; Andre, Pascale

• Source: Regular and Young Investigator Award Abstracts ; page A1203-A1203

Record details

244 A phase 1 study of novel transposon-based BAFF CAR-T cells (LMY-920) for treatment of relapsed or refractory non-hodgkin lymphoma (NHL)

• Authors : Caimi, Paolo; Spear, Matthew A; Liter, Jeff

• Source: Regular and Young Investigator Award Abstracts ; page A282-A282

Record details

ABVD (8 cycles) vs. BEACOPP (4 escalated cycles => 4 baseline) in stage III - IV low risk Hodgkin Lymphoma (IPS 0-2): final results of LYSA H34 trial

• Authors : André, M.; DE PRIJCK, Bernard; Kentos, A.

Subjects: Human health sciences :: Hematology; Sciences de la santé humaine :: Hématologie

• Source: ABVD (8 cycles) vs. BEACOPP (4 escalated cycles => 4 baseline) in stage III - IV low risk Hodgkin Lymphoma (IPS 0-2): final results of

Record details

Differentially Expressed Genes In Recurrent Classical Hodgkin Lymphoma And Exploring The Potential For Repurposed Drugs

• Authors : Nazir, Ahad Ali; Shirdel, Madina; Khan, Faisal

Record details